Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.
Identifieur interne : 000253 ( PubMed/Corpus ); précédent : 000252; suivant : 000254Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.
Auteurs : Dariush Mozaffarian ; Roberto Marchioli ; Alejandro Macchia ; Maria G. Silletta ; Paolo Ferrazzi ; Timothy J. Gardner ; Roberto Latini ; Peter Libby ; Federico Lombardi ; Patrick T. O'Gara ; Richard L. Page ; Luigi Tavazzi ; Gianni TognoniSource :
- JAMA ; 2012.
English descriptors
- KwdEn :
- Aged, Atrial Fibrillation (etiology), Atrial Fibrillation (prevention & control), Cardiovascular Surgical Procedures (adverse effects), Dietary Supplements, Double-Blind Method, Fatty Acids, Omega-3 (therapeutic use), Female, Fish Oils (therapeutic use), Humans, Male, Middle Aged, Odds Ratio, Risk, Treatment Outcome.
- MESH :
- chemical , therapeutic use : Fatty Acids, Omega-3, Fish Oils.
- adverse effects : Cardiovascular Surgical Procedures.
- etiology : Atrial Fibrillation.
- prevention & control : Atrial Fibrillation.
- Aged, Dietary Supplements, Double-Blind Method, Female, Humans, Male, Middle Aged, Odds Ratio, Risk, Treatment Outcome.
Abstract
Postoperative atrial fibrillation or flutter (AF) is one of the most common complications of cardiac surgery and significantly increases morbidity and health care utilization. A few small trials have evaluated whether long-chain n-3-polyunsaturated fatty acids (PUFAs) reduce postoperative AF, with mixed results.
DOI: 10.1001/jama.2012.28733
PubMed: 23128104
Links to Exploration step
pubmed:23128104Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.</title>
<author><name sortKey="Mozaffarian, Dariush" sort="Mozaffarian, Dariush" uniqKey="Mozaffarian D" first="Dariush" last="Mozaffarian">Dariush Mozaffarian</name>
<affiliation><nlm:affiliation>Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. dmozaffa@hsph.harvard.edu</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Marchioli, Roberto" sort="Marchioli, Roberto" uniqKey="Marchioli R" first="Roberto" last="Marchioli">Roberto Marchioli</name>
</author>
<author><name sortKey="Macchia, Alejandro" sort="Macchia, Alejandro" uniqKey="Macchia A" first="Alejandro" last="Macchia">Alejandro Macchia</name>
</author>
<author><name sortKey="Silletta, Maria G" sort="Silletta, Maria G" uniqKey="Silletta M" first="Maria G" last="Silletta">Maria G. Silletta</name>
</author>
<author><name sortKey="Ferrazzi, Paolo" sort="Ferrazzi, Paolo" uniqKey="Ferrazzi P" first="Paolo" last="Ferrazzi">Paolo Ferrazzi</name>
</author>
<author><name sortKey="Gardner, Timothy J" sort="Gardner, Timothy J" uniqKey="Gardner T" first="Timothy J" last="Gardner">Timothy J. Gardner</name>
</author>
<author><name sortKey="Latini, Roberto" sort="Latini, Roberto" uniqKey="Latini R" first="Roberto" last="Latini">Roberto Latini</name>
</author>
<author><name sortKey="Libby, Peter" sort="Libby, Peter" uniqKey="Libby P" first="Peter" last="Libby">Peter Libby</name>
</author>
<author><name sortKey="Lombardi, Federico" sort="Lombardi, Federico" uniqKey="Lombardi F" first="Federico" last="Lombardi">Federico Lombardi</name>
</author>
<author><name sortKey="O Gara, Patrick T" sort="O Gara, Patrick T" uniqKey="O Gara P" first="Patrick T" last="O'Gara">Patrick T. O'Gara</name>
</author>
<author><name sortKey="Page, Richard L" sort="Page, Richard L" uniqKey="Page R" first="Richard L" last="Page">Richard L. Page</name>
</author>
<author><name sortKey="Tavazzi, Luigi" sort="Tavazzi, Luigi" uniqKey="Tavazzi L" first="Luigi" last="Tavazzi">Luigi Tavazzi</name>
</author>
<author><name sortKey="Tognoni, Gianni" sort="Tognoni, Gianni" uniqKey="Tognoni G" first="Gianni" last="Tognoni">Gianni Tognoni</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="doi">10.1001/jama.2012.28733</idno>
<idno type="RBID">pubmed:23128104</idno>
<idno type="pmid">23128104</idno>
<idno type="wicri:Area/PubMed/Corpus">000253</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.</title>
<author><name sortKey="Mozaffarian, Dariush" sort="Mozaffarian, Dariush" uniqKey="Mozaffarian D" first="Dariush" last="Mozaffarian">Dariush Mozaffarian</name>
<affiliation><nlm:affiliation>Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. dmozaffa@hsph.harvard.edu</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Marchioli, Roberto" sort="Marchioli, Roberto" uniqKey="Marchioli R" first="Roberto" last="Marchioli">Roberto Marchioli</name>
</author>
<author><name sortKey="Macchia, Alejandro" sort="Macchia, Alejandro" uniqKey="Macchia A" first="Alejandro" last="Macchia">Alejandro Macchia</name>
</author>
<author><name sortKey="Silletta, Maria G" sort="Silletta, Maria G" uniqKey="Silletta M" first="Maria G" last="Silletta">Maria G. Silletta</name>
</author>
<author><name sortKey="Ferrazzi, Paolo" sort="Ferrazzi, Paolo" uniqKey="Ferrazzi P" first="Paolo" last="Ferrazzi">Paolo Ferrazzi</name>
</author>
<author><name sortKey="Gardner, Timothy J" sort="Gardner, Timothy J" uniqKey="Gardner T" first="Timothy J" last="Gardner">Timothy J. Gardner</name>
</author>
<author><name sortKey="Latini, Roberto" sort="Latini, Roberto" uniqKey="Latini R" first="Roberto" last="Latini">Roberto Latini</name>
</author>
<author><name sortKey="Libby, Peter" sort="Libby, Peter" uniqKey="Libby P" first="Peter" last="Libby">Peter Libby</name>
</author>
<author><name sortKey="Lombardi, Federico" sort="Lombardi, Federico" uniqKey="Lombardi F" first="Federico" last="Lombardi">Federico Lombardi</name>
</author>
<author><name sortKey="O Gara, Patrick T" sort="O Gara, Patrick T" uniqKey="O Gara P" first="Patrick T" last="O'Gara">Patrick T. O'Gara</name>
</author>
<author><name sortKey="Page, Richard L" sort="Page, Richard L" uniqKey="Page R" first="Richard L" last="Page">Richard L. Page</name>
</author>
<author><name sortKey="Tavazzi, Luigi" sort="Tavazzi, Luigi" uniqKey="Tavazzi L" first="Luigi" last="Tavazzi">Luigi Tavazzi</name>
</author>
<author><name sortKey="Tognoni, Gianni" sort="Tognoni, Gianni" uniqKey="Tognoni G" first="Gianni" last="Tognoni">Gianni Tognoni</name>
</author>
</analytic>
<series><title level="j">JAMA</title>
<idno type="e-ISSN">1538-3598</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Atrial Fibrillation (etiology)</term>
<term>Atrial Fibrillation (prevention & control)</term>
<term>Cardiovascular Surgical Procedures (adverse effects)</term>
<term>Dietary Supplements</term>
<term>Double-Blind Method</term>
<term>Fatty Acids, Omega-3 (therapeutic use)</term>
<term>Female</term>
<term>Fish Oils (therapeutic use)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Odds Ratio</term>
<term>Risk</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Fatty Acids, Omega-3</term>
<term>Fish Oils</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Cardiovascular Surgical Procedures</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Atrial Fibrillation</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Atrial Fibrillation</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Dietary Supplements</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Odds Ratio</term>
<term>Risk</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Postoperative atrial fibrillation or flutter (AF) is one of the most common complications of cardiac surgery and significantly increases morbidity and health care utilization. A few small trials have evaluated whether long-chain n-3-polyunsaturated fatty acids (PUFAs) reduce postoperative AF, with mixed results.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">23128104</PMID>
<DateCreated><Year>2012</Year>
<Month>11</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted><Year>2012</Year>
<Month>11</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>02</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>308</Volume>
<Issue>19</Issue>
<PubDate><Year>2012</Year>
<Month>Nov</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>JAMA</Title>
<ISOAbbreviation>JAMA</ISOAbbreviation>
</Journal>
<ArticleTitle>Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.</ArticleTitle>
<Pagination><MedlinePgn>2001-11</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Postoperative atrial fibrillation or flutter (AF) is one of the most common complications of cardiac surgery and significantly increases morbidity and health care utilization. A few small trials have evaluated whether long-chain n-3-polyunsaturated fatty acids (PUFAs) reduce postoperative AF, with mixed results.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine whether perioperative n-3-PUFA supplementation reduces postoperative AF.</AbstractText>
<AbstractText Label="DESIGN, SETTING, AND PATIENTS" NlmCategory="METHODS">The Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) double-blind, placebo-controlled, randomized clinical trial. A total of 1516 patients scheduled for cardiac surgery in 28 centers in the United States, Italy, and Argentina were enrolled between August 2010 and June 2012. Inclusion criteria were broad; the main exclusions were regular use of fish oil or absence of sinus rhythm at enrollment.</AbstractText>
<AbstractText Label="INTERVENTION" NlmCategory="METHODS">Patients were randomized to receive fish oil (1-g capsules containing ≥840 mg n-3-PUFAs as ethyl esters) or placebo, with preoperative loading of 10 g over 3 to 5 days (or 8 g over 2 days) followed postoperatively by 2 g/d until hospital discharge or postoperative day 10, whichever came first.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE" NlmCategory="METHODS">Occurrence of postoperative AF lasting longer than 30 seconds. Secondary end points were postoperative AF lasting longer than 1 hour, resulting in symptoms, or treated with cardioversion; postoperative AF excluding atrial flutter; time to first postoperative AF; number of AF episodes per patient; hospital utilization; and major adverse cardiovascular events, 30-day mortality, bleeding, and other adverse events.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">At enrollment, mean age was 64 (SD, 13) years; 72.2% of patients were men, and 51.8% had planned valvular surgery. The primary end point occurred in 233 (30.7%) patients assigned to placebo and 227 (30.0%) assigned to n-3-PUFAs (odds ratio, 0.96 [95% CI, 0.77-1.20]; P = .74). None of the secondary end points were significantly different between the placebo and fish oil groups, including postoperative AF that was sustained, symptomatic, or treated (231 [30.5%] vs 224 [29.6%], P = .70) or number of postoperative AF episodes per patient (1 episode: 156 [20.6%] vs 157 [20.7%]; 2 episodes: 59 [7.8%] vs 49 [6.5%]; ≥3 episodes: 18 [2.4%] vs 21 [2.8%]) (P = .73). Supplementation with n-3-PUFAs was generally well tolerated, with no evidence for increased risk of bleeding or serious adverse events.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this large multinational trial among patients undergoing cardiac surgery, perioperative supplementation with n-3-PUFAs, compared with placebo, did not reduce the risk of postoperative AF. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT00970489.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mozaffarian</LastName>
<ForeName>Dariush</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. dmozaffa@hsph.harvard.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Marchioli</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Macchia</LastName>
<ForeName>Alejandro</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Silletta</LastName>
<ForeName>Maria G</ForeName>
<Initials>MG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ferrazzi</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gardner</LastName>
<ForeName>Timothy J</ForeName>
<Initials>TJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Latini</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Libby</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lombardi</LastName>
<ForeName>Federico</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>O'Gara</LastName>
<ForeName>Patrick T</ForeName>
<Initials>PT</Initials>
</Author>
<Author ValidYN="Y"><LastName>Page</LastName>
<ForeName>Richard L</ForeName>
<Initials>RL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tavazzi</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tognoni</LastName>
<ForeName>Gianni</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><CollectiveName>OPERA Investigators</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList><AccessionNumber>NCT00970489</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y"><Grant><GrantID>RC2 HL101816</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>RC2-HL101816</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>JAMA</MedlineTA>
<NlmUniqueID>7501160</NlmUniqueID>
<ISSNLinking>0098-7484</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015525">Fatty Acids, Omega-3</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005395">Fish Oils</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biochem. 2000 Mar;206(1-2):33-41</RefSource>
<PMID Version="1">10839192</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Am Coll Cardiol. 2011 Nov 8;58(20):2047-67</RefSource>
<PMID Version="1">22051327</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lipids. 2001;36 Suppl:S111-4</RefSource>
<PMID Version="1">11837983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2011 Sep 6;124(10):1100-6</RefSource>
<PMID Version="1">21844082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Cardiol. 2011 Sep 15;108(6):851-6</RefSource>
<PMID Version="1">21762871</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2012 Sep 12;308(10):1024-33</RefSource>
<PMID Version="1">22968891</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Am Coll Nutr. 2012 Feb;31(1):4-13</RefSource>
<PMID Version="1">22661621</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Heart Rhythm. 2012 Apr;9(4):483-91</RefSource>
<PMID Version="1">22120130</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2012 Mar 6;125(9):1084-93</RefSource>
<PMID Version="1">22282329</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Monaldi Arch Chest Dis. 2011 Jun;76(2):93-8</RefSource>
<PMID Version="1">22128614</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2002 Apr 23;105(16):1897-903</RefSource>
<PMID Version="1">11997274</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Crit Care. 2002 May;11(3):228-38</RefSource>
<PMID Version="1">12022486</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2003 Feb 8;361(9356):477-85</RefSource>
<PMID Version="1">12583947</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Heart J. 2003 May;24(9):881-2</RefSource>
<PMID Version="1">12727160</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2003 Jun 3;107(21):2646-52</RefSource>
<PMID Version="1">12782616</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2004 Jul 27;110(4):368-73</RefSource>
<PMID Version="1">15262826</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1989 Jul 22;2(8656):177-81</RefSource>
<PMID Version="1">2568519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1989 Sep 30;2(8666):757-61</RefSource>
<PMID Version="1">2571009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb. 1991 Jul-Aug;11(4):903-11</RefSource>
<PMID Version="1">1829632</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood Coagul Fibrinolysis. 1995 Feb;6(1):17-22</RefSource>
<PMID Version="1">7795149</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 1996 Jul 24-31;276(4):300-6</RefSource>
<PMID Version="1">8656542</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Cardiothorac Surg. 1999 Jul;16(1):9-13</RefSource>
<PMID Version="1">10456395</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1999 Aug 7;354(9177):447-55</RefSource>
<PMID Version="1">10465168</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Am Coll Cardiol. 2005 May 17;45(10):1723-8</RefSource>
<PMID Version="1">15893193</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Chest. 2005 Aug;128(2 Suppl):9S-16S</RefSource>
<PMID Version="1">16167659</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cardiovasc Surg (Torino). 2005 Dec;46(6):583-8</RefSource>
<PMID Version="1">16424847</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2006 Oct 18;296(15):1885-99</RefSource>
<PMID Version="1">17047219</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Heart J. 2006 Dec;27(23):2846-57</RefSource>
<PMID Version="1">17015402</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2008 Oct 14;118(16):1612-8</RefSource>
<PMID Version="1">18824644</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Heart J. 2009 Apr;30(7):820-6</RefSource>
<PMID Version="1">19196720</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Thorac Cardiovasc Surg. 2009 Aug;57(5):276-80</RefSource>
<PMID Version="1">19629889</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circ Arrhythm Electrophysiol. 2010 Feb;3(1):46-53</RefSource>
<PMID Version="1">20042769</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Europace. 2010 Mar;12(3):356-63</RefSource>
<PMID Version="1">20061328</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Heart J. 2010 Oct;31(19):2369-429</RefSource>
<PMID Version="1">20802247</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2010 Dec 1;304(21):2363-72</RefSource>
<PMID Version="1">21078810</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Europace. 2011 Feb;13(2):174-81</RefSource>
<PMID Version="1">21059740</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am Heart J. 2011 Feb;161(2):338-343.e1</RefSource>
<PMID Version="1">21315217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Can J Cardiol. 2011 Jan-Feb;27(1):91-7</RefSource>
<PMID Version="1">21329866</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Heart Rhythm. 2011 Apr;8(4):562-8</RefSource>
<PMID Version="1">21147262</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Anadolu Kardiyol Derg. 2011 Jun;11(4):305-9</RefSource>
<PMID Version="1">21543294</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am Heart J. 2011 Jul;162(1):56-63.e3</RefSource>
<PMID Version="1">21742090</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Cardiol. 2011 Aug 15;108(4):531-5</RefSource>
<PMID Version="1">21624541</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2013 Mar 6;309(9):871-2</RefSource>
<PMID Version="1">23462775</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2013 Mar 6;309(9):871</RefSource>
<PMID Version="1">23462774</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="ErratumIn"><RefSource>JAMA. 2013 Mar 6;309(9):876</RefSource>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001281">Atrial Fibrillation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013504">Cardiovascular Surgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D019587">Dietary Supplements</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004311">Double-Blind Method</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D015525">Fatty Acids, Omega-3</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005395">Fish Oils</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016017">Odds Ratio</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012306">Risk</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS479252</OtherID>
<OtherID Source="NLM">PMC3694745</OtherID>
<InvestigatorList><Investigator ValidYN="Y"><LastName>Marchioli</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mozaffarian</LastName>
<ForeName>Dariush</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gardner</LastName>
<ForeName>Timothy J</ForeName>
<Initials>TJ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ferrazzi</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>O'Gara</LastName>
<ForeName>Patrick T</ForeName>
<Initials>PT</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Macchia</LastName>
<ForeName>Alejandro</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Santini</LastName>
<ForeName>Massimo</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tavazzi</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tognoni</LastName>
<ForeName>Gianni</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Page</LastName>
<ForeName>Richard L</ForeName>
<Initials>RL</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lombardi</LastName>
<ForeName>Federico</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Albert</LastName>
<ForeName>Christine M</ForeName>
<Initials>CM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Maggioni</LastName>
<ForeName>Aldo P</ForeName>
<Initials>AP</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Murray</LastName>
<ForeName>Katherine T</ForeName>
<Initials>KT</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Latini</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Libby</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Harris</LastName>
<ForeName>Bill</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Saffitz</LastName>
<ForeName>Jeffery E</ForeName>
<Initials>JE</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Siscovick</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Stein</LastName>
<ForeName>Phyllis</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Corradi</LastName>
<ForeName>Domenico</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Masson</LastName>
<ForeName>Serge</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Brown</LastName>
<ForeName>Nancy J</ForeName>
<Initials>NJ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ely</LastName>
<ForeName>E Wesley</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jackson</LastName>
<ForeName>James C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Shintani</LastName>
<ForeName>Ayumi</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Milne</LastName>
<ForeName>Ginger L</ForeName>
<Initials>GL</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Song</LastName>
<ForeName>Xiaoling</ForeName>
<Initials>X</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sellke</LastName>
<ForeName>Frank W</ForeName>
<Initials>FW</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Silletta</LastName>
<ForeName>Maria G</ForeName>
<Initials>MG</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pioggiarella</LastName>
<ForeName>Raffaella</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Marfisi</LastName>
<ForeName>Lorenzo</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>King</LastName>
<ForeName>Sarah L</ForeName>
<Initials>SL</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mills</LastName>
<ForeName>Kristen E</ForeName>
<Initials>KE</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ogunleye</LastName>
<ForeName>Adeyemi</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Schelling</LastName>
<ForeName>Namasha H</ForeName>
<Initials>NH</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wu</LastName>
<ForeName>Jason</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ferrazzi</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Simon</LastName>
<ForeName>Caterina</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Iascone</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sinatra</LastName>
<ForeName>Riccardo</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Benedetto</LastName>
<ForeName>Umberto</ForeName>
<Initials>U</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dreas</LastName>
<ForeName>Lorella</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Aleksova</LastName>
<ForeName>Aneta</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rinaldi</LastName>
<ForeName>Mauro</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Salizzoni</LastName>
<ForeName>Stefano</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Marchetto</LastName>
<ForeName>Giovanni</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lamarra</LastName>
<ForeName>Mauro</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pagliaro</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jori</LastName>
<ForeName>Maria Cristina</ForeName>
<Initials>MC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dozza</LastName>
<ForeName>Luca</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Calvi</LastName>
<ForeName>Simone</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Casabona</LastName>
<ForeName>Riccardo</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zingarelli</LastName>
<ForeName>Edoardo</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Flocco</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Eusebio</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Raffa</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tarelli</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Parolari</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cavallotti</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Miyasoedova</LastName>
<ForeName>Veronica</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Laguzzi</LastName>
<ForeName>Federica</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gregorini</LastName>
<ForeName>Renato</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mangia</LastName>
<ForeName>Federica</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gazzoli</LastName>
<ForeName>Fabrizio</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Raviola</LastName>
<ForeName>Eliana</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Viganò</LastName>
<ForeName>Mario</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Livi</LastName>
<ForeName>Ugolino</ForeName>
<Initials>U</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pompei</LastName>
<ForeName>Esmeralda</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Salvador</LastName>
<ForeName>Loris</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lamascese</LastName>
<ForeName>Nicola</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bilotta</LastName>
<ForeName>Massimo</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Martinelli</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cannata</LastName>
<ForeName>Aldo</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Brown</LastName>
<ForeName>Nancy J</ForeName>
<Initials>NJ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Byrne</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Leacche</LastName>
<ForeName>Marzia</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Petracek</LastName>
<ForeName>Michael R</ForeName>
<Initials>MR</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ball</LastName>
<ForeName>Stephen K</ForeName>
<Initials>SK</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jessen</LastName>
<ForeName>Michael E</ForeName>
<Initials>ME</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Weyant</LastName>
<ForeName>Mary</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Damiano</LastName>
<ForeName>Ralph J</ForeName>
<Initials>RJ</Initials>
<Suffix>Jr</Suffix>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sellke</LastName>
<ForeName>Frank W</ForeName>
<Initials>FW</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Singh</LastName>
<ForeName>Arun K</ForeName>
<Initials>AK</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>McDonald</LastName>
<ForeName>Mary Jane</ForeName>
<Initials>MJ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bolman</LastName>
<ForeName>R Morton</ForeName>
<Initials>R</Initials>
<Suffix>3rd</Suffix>
</Investigator>
<Investigator ValidYN="Y"><LastName>Conboy</LastName>
<ForeName>Debra A</ForeName>
<Initials>DA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Burgess</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Puskas</LastName>
<ForeName>John D</ForeName>
<Initials>JD</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>VanderWoude</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<Suffix>Jr</Suffix>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bell</LastName>
<ForeName>Maria C</ForeName>
<Initials>MC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sethi</LastName>
<ForeName>Gulshan</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lee</LastName>
<ForeName>Daniel C</ForeName>
<Initials>DC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Favaloro</LastName>
<ForeName>Roberto René</ForeName>
<Initials>RR</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hershson</LastName>
<ForeName>Alejandro Rubén</ForeName>
<Initials>AR</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Figal</LastName>
<ForeName>Julio César</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Domenech</LastName>
<ForeName>Alberto</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Halac</LastName>
<ForeName>Marcelo</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Nicolosi</LastName>
<ForeName>Liliana Noemí</ForeName>
<Initials>LN</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Morós</LastName>
<ForeName>Claudio Gabriel</ForeName>
<Initials>CG</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rubio</LastName>
<ForeName>María del Carmen</ForeName>
<Initials>Mdel C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Suárez</LastName>
<ForeName>Richard Fuentes</ForeName>
<Initials>RF</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cacheda</LastName>
<ForeName>Horacio</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Casal</LastName>
<ForeName>Juan Pablo</ForeName>
<Initials>JP</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Medrano</LastName>
<ForeName>Juan Carlos</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cucurell</LastName>
<ForeName>María Carla</ForeName>
<Initials>MC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Scattini</LastName>
<ForeName>Florencia</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Nojek</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Camporrotondo</LastName>
<ForeName>Mariano</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mozaffarian</LastName>
</Investigator>
<Investigator ValidYN="Y"><LastName>Silletta</LastName>
</Investigator>
<Investigator ValidYN="Y"><LastName>Scarano</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Herrington</LastName>
<ForeName>David M</ForeName>
<Initials>DM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Brooks</LastName>
<ForeName>Maria Mori</ForeName>
<Initials>MM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>De Caterina</LastName>
<ForeName>Raffaele</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gillinov</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Padeletti</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pellegrini</LastName>
<ForeName>Fabio</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rothschild</LastName>
<ForeName>Barbra Bluestone</ForeName>
<Initials>BB</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rubinstein</LastName>
<ForeName>Fernando</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Diep</LastName>
<ForeName>Pho Q</ForeName>
<Initials>PQ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Guzman</LastName>
<ForeName>Junitta B</ForeName>
<Initials>JB</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Palmarini</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sacchetti</LastName>
<ForeName>Stefania</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Flamminio</LastName>
<ForeName>Anna V</ForeName>
<Initials>AV</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Marfisi</LastName>
<ForeName>Rosamaria</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Scarano</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Afshin</LastName>
<ForeName>Ashkan</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Hongyan</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Otite</LastName>
<ForeName>Fadar</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ambrosio</LastName>
<ForeName>Marilisa</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lincesso</LastName>
<ForeName>Annarita</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pezzoli</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Anzini</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Carriere</LastName>
<ForeName>Cosimo</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Belfiore</LastName>
<ForeName>Rita</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Fortunato</LastName>
<ForeName>Guglielmo</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pellegrini</LastName>
<ForeName>Augusto</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Raviola</LastName>
<ForeName>Eliana</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Reale</LastName>
<ForeName>Vincenzo</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sorrentino</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Schiavina</LastName>
<ForeName>Giulia</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Negrosanti</LastName>
<ForeName>Monica</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ravenni</LastName>
<ForeName>Giacomo</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Moro</LastName>
<ForeName>Franco</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Brambilla</LastName>
<ForeName>Marta</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Nava</LastName>
<ForeName>Cristina</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Giroli</LastName>
<ForeName>Monica</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Daprati</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gennari</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cusihuaman</LastName>
<ForeName>Dennis Ezra Puma</ForeName>
<Initials>DE</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Spagnolo</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Francia</LastName>
<ForeName>Michela</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Stanca</LastName>
<ForeName>Maurizio</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Paris</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Berwick</LastName>
<ForeName>Daniele</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lusona</LastName>
<ForeName>Bruno</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Castiglione</LastName>
<ForeName>Nicoletta</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>De Biasio</LastName>
<ForeName>Marzia</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Daffarra</LastName>
<ForeName>Cristian</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ahmad</LastName>
<ForeName>Rashid</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Meisch</LastName>
<ForeName>Carol A</ForeName>
<Initials>CA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Maltais</LastName>
<ForeName>Simon</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Balaguer</LastName>
<ForeName>Jorge</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Donahue</LastName>
<ForeName>Tamara</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Guyton</LastName>
<ForeName>Robert A</ForeName>
<Initials>RA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Thourani</LastName>
<ForeName>Vinod</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Halkos</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lattouf</LastName>
<ForeName>Omar</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Baio</LastName>
<ForeName>Kim T</ForeName>
<Initials>KT</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Levine</LastName>
<ForeName>Samatha R</ForeName>
<Initials>SR</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pitts</LastName>
<ForeName>Zachary E</ForeName>
<Initials>ZE</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Janssen</LastName>
<ForeName>Kathy</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ruhlman</LastName>
<ForeName>Marilyn</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sharp</LastName>
<ForeName>Sarah</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pang</LastName>
<ForeName>Kristy</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mungo</LastName>
<ForeName>Matías Nicolás</ForeName>
<Initials>MN</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Servián</LastName>
<ForeName>Ada Liz</ForeName>
<Initials>AL</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Battellini</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Marenchino</LastName>
<ForeName>Ricardo</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kotowicz</LastName>
<ForeName>Vadim</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cesáreo</LastName>
<ForeName>Vicente</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sánchez</LastName>
<ForeName>Ricardo</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Romero</LastName>
<ForeName>Veronica</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Avila</LastName>
<ForeName>Silvia</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Donnini</LastName>
<ForeName>Fabian</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Biancospino</LastName>
<ForeName>Leticia</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Laurino</LastName>
<ForeName>Romina</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Portalea</LastName>
<ForeName>Rodolfo</ForeName>
<Initials>R</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>11</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>11</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>12</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pii">1389226</ArticleId>
<ArticleId IdType="doi">10.1001/jama.2012.28733</ArticleId>
<ArticleId IdType="pubmed">23128104</ArticleId>
<ArticleId IdType="pmc">PMC3694745</ArticleId>
<ArticleId IdType="mid">NIHMS479252</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000253 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000253 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Musique |area= OperaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:23128104 |texte= Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:23128104" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a OperaV1
This area was generated with Dilib version V0.6.21. |